TrialThe New England journal of medicine2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
978 papers cite itlatest 60 shown
this paperpooled ittrialcites it